Bicara Therapeutics Inc Annual Shareholders Meeting Transcript
Good morning, everyone. Welcome to the 2026 Bicara Therapeutics Annual Meeting of Stockholders. Please note that today's meeting is being recorded. My name is Claire Mazumdar, Chief Executive Officer of the company, and I will serve as the chairperson for today's meeting. The annual meeting of stockholders is now called to order. I've asked Gabriela Morales Rivera of Goodwin Procter, our outside legal counsel, to record the minutes.
Before we proceed, I would like to let you know that members of our Board and our management team have joined us virtually. Also with us today are representatives from KPMG, the company's independent registered public accounting firm.
The rules of conduct for this meeting are available in the file section in the lower right-hand corner of the screen. Now let's proceed with the formal business of the meeting. This meeting is being held in accordance with the company's bylaws and Delaware law.
The matters to be considered at this meeting are described in our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

